|
DrugPatentWatch concentrates deep knowledge on more than 6,400 small-molecule drugs and 2,300 generic ingredients from 1,700 branded and generic pharmaceutical companies and 700 suppliers, and more than 4,300 active and expired US patents and 74,000 international patents spanning 93 countries and regional patent offices. |
Tradename: NUTROPIN DEPOT
Summary for Tradename: NUTROPIN DEPOT
|
| |||||||
Clinical Trials for: NUTROPIN DEPOTAn Open-label Phase 4 Study to Explore Immunogenicity of the Liquid Formulation of Saizen® in Subjects With Growth Hormone Deficiency (GHD) of Adult Onset Status: Not yet recruiting Condition: Growth Hormone Deficiency Saizen® Solution for Injection Adult Growth Hormone Deficiency (GHD) Immunogenicity Study Status: Terminated Condition: Growth Hormone Deficiency (GHD) Efficiency and Safety Study of Pegylated Somatropin to Treat Growth Hormone Deficiency Children Status: Completed Condition: Growth Hormone Deficiency Cool.Click™ Adolescent Transition Study: Study of Saizen® in Subjects With Childhood-onset Growth Hormone Deficiency Status: Completed Condition: Childhood-onset Growth Hormone Deficiency; Pituitary Dwarfism A Trial Investigating the Safety, Tolerability, Availability and Distribution in the Body of Once-weekly Long-acting Growth Hormone Compared to Once Daily Norditropin NordiFlex® in Adults With Growth Hormone Deficiency Status: Recruiting Condition: Growth Hormone Disorder; Adult Growth Hormone Deficiency Crossover Study to Assess the Safety and Pharmacokinetic of Pegylated Somatropin(PEG Somatropin) in GHD Children Status: Completed Condition: Growth Hormone Deficiency Phase III Clinical Study of Pegylated Somatropin (PEG Somatropin) to Treat Growth Hormone Deficiency Children Status: Completed Condition: Growth Hormone Deficiency American Norditropin Studies - Registry of Growth Hormone (GH) Patients Status: Suspended Condition: Growth Hormone Deficiency Surveillance of Treatment of Children With Growth Hormone Deficiency With Zomacton® Status: Withdrawn Condition: Growth Hormone Deficiency A Prospective Observational Study of Effect of Somatropin on Growth Hormone Deficient Adults Status: Completed Condition: Hypopituitarism; Pituitary Insufficiency; Growth Hormone Deficiency, Adult Courtesy of ClinicalTrials.org See more clinical trials for this drug | ||||||||
Glossary
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Product | Substance | Delist_Flag | Patent Expiration | Exclusivity Expiration | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Genentech | NUTROPIN DEPOT | somatropin recombinant | INJECTABLE; INJECTION | 021075 | Dec 22, 1999 | DISCN | No | 5,654,010 | <disabled> | <disabled> | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Genentech | NUTROPIN DEPOT | somatropin recombinant | INJECTABLE; INJECTION | 021075 | Dec 22, 1999 | DISCN | No | 5,656,297 | <disabled> | <disabled> | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Genentech | NUTROPIN DEPOT | somatropin recombinant | INJECTABLE; INJECTION | 021075 | Dec 22, 1999 | DISCN | No | 6,051,259 | <disabled> | <disabled> | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| The preview shows a limited data set. Complete access is available with a Subscription | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
« Back to Dashboard
DrugPatentWatch Archives
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Connect with Social Media:
Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639
`abc